Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Gynecologic 1Breast 1

Conditions

Lung Neoplasms 3Ovarian Neoplasms 2Neoplasms 2Colonic Neoplasms 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Hyperthermia 1Head and Neck Neoplasms 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Adenocarcinoma, Bronchiolo-Alveolar 1

Interventions

pembrolizumab 7Ipilimumab 5Nivolumab 4fludarabine 3Radiosurgery 3Drug Therapy 3Cyclophosphamide 3spartalizumab 2aldesleukin 2Sirolimus 2Riluzole 2Radiotherapy 2Psychiatric Rehabilitation 2Polymerase Chain Reaction 2Oncolytic Virotherapy 2Counseling 2Bupropion 2Blood Specimen Collection 2vofatamab 1utomilumab 1trastuzumab deruxtecan 1toripalimab 1tocilizumab 1sargramostim 1saracatinib 1pertuzumab 1pazopanib 1liposomal doxorubicin 1ixabepilone 1fostamatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × Diathermy × Thoracic × Clear all
NCT07224464 2026-05-15

The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.

New Phase Ltd.

Phase NA Recruiting
12 enrolled
BreastGastrointestinalGynecologicThoracic

Hyperthermia, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡